The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

$8.14

Movement

0.04 (+0.49%)

As at 16 Apr - Closed (20 mins delayed)

52 Week Range

$4.73 - $9.08

 
1 Year Return

+45.62%

The a2 Milk Co Ltd Chart and Price Data

2025
2025
2025
2025
$0
$5
$10
$0
$5
$10
$0
$5
$10
$0
$5
$10

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $5.86 billion
P/E Ratio 37.69
Dividend Yield 0.82%
Shares Outstanding 724.02 million
Earnings per share 0.231
Dividend per share 0.13
Year To Date Return 40.58%
Earnings Yield 2.65%
Franking -
Earnings Yield

2.65%

Franking

-

Dividend per share

0.13

Year To Date Return

40.58%

Shares Outstanding

724.02 million

Earnings per share

0.231

Share Price

$8.14

Day Change

0.04 (+0.49%)

52 Week Range

$4.73 - $9.08

Yesterday's Close

$8.10

Today's Open

$8.10

Days Range

$8.01 - $8.18

Volume

1,496,330

Avg. Volume (1 month)

3,554,349

Turnover

$12,128,580

As at 16 Apr - Closed

The a2 Milk Co Ltd (ASX: A2M)
Latest News

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
Earnings Results

A2 Milk share price crashes 24% on FY24 results

This high-flying stock is having its wings clipped on Monday.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

Why A2 Milk, Fortescue, Imdex, and Magellan shares are roaring higher today

These shares are ending the week on a high. But why?

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Consumer Staples & Discretionary Shares

A2 Milk shares storm 6% higher on peace deal with Synlait Milk

Investors are celebrating the settlement of this dispute. What happened?

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares ran out of steam this Tuesday and finished lower...

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Consumer Staples & Discretionary Shares

What are brokers saying about A2 Milk, Breville, and Treasury Wine shares?

Goldman Sachs has given its verdict on these stocks.

Read more »

dairy asx share price represented by grandfather and grandson both drinking glasses of milk
Consumer Staples & Discretionary Shares

Here's why A2 Milk shares soared in FY24. Will it happen again?

It turned out to be a stellar year for the milk company's shareholders.

Read more »

smiling child drinking milk from a glass, A2 milk share price rise, increase, up, A2 sales to china
Consumer Staples & Discretionary Shares

A2 Milk shares lift amid backing for $130 million Synlait loan

A2 Milk is throwing its support behind the $130 million Synlait shareholder loan.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Share Gainers

Why A2 Milk, Actinogen Medical, Karoon Energy, and Race Oncology shares are rising

These shares are avoiding the market weakness on Wednesday. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Today's trading gave ASX investors some much-needed relief.

Read more »

a cute young girl with curly hair sips a glass of milk through a straw with a smile on her face.
Consumer Staples & Discretionary Shares

Guess which A2 Milk rival's shares just rocketed 21% on US news!

Up 65% in 2024, A2 Milk shares remain the better performer, but this rival is making up ground today.

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Cheap Shares

2 cash-rich ASX companies to buy now

Here are two ASX-listed shares boasting substantial cash reserves.

Read more »

Older man and young boy smiling while drinking milk with milk moustaches
Consumer Staples & Discretionary Shares

Here is the earnings forecast out to 2026 for A2 Milk shares

A2 Milk earnings are projected to be on a good trajectory.

Read more »

Frequently Asked Questions

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
20 Mar 2025 $0.0650 0.00% Interim 04 Apr 2025

A2M ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
14th Apr 2025 2025-04-14T09:06:18 Notification of cessation of securities - A2MYesNo9:06am413k
11th Apr 2025 2025-04-11T14:52:52 Ceasing to be a substantial holderYesNo2:52pm4113k
10th Apr 2025 2025-04-10T09:16:29 Becoming a substantial holderYesNo9:16am1442.9M
9th Apr 2025 2025-04-09T11:55:08 Ceasing to be a substantial holderYesNo11:55am29327k
9th Apr 2025 2025-04-09T09:35:13 Ceasing to be a substantial holderYesNo9:35am1113.4M
28th Mar 2025 2025-03-28T15:14:34 Becoming a substantial holderYesNo3:14pm485k
27th Mar 2025 2025-03-27T18:56:28 Ceasing to be a substantial holderYesNo6:56pm484k
27th Mar 2025 2025-03-27T08:00:35 Update - Dividend/Distribution - A2MYesNo8:00am518k
25th Feb 2025 2025-02-25T09:38:22 Notification regarding unquoted securities - A2MYesNo9:38am616k
18th Feb 2025 2025-02-18T14:57:48 Becoming a substantial holderYesNo2:57pm482k

About The a2 Milk Co Ltd

A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

A2M Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
15 Apr 2025 $8.10 $0.04 0.50% 1,558,710 $8.14 $8.22 $8.07
14 Apr 2025 $8.06 $-0.25 -3.01% 1,566,264 $8.36 $8.40 $8.04
11 Apr 2025 $8.31 $0.10 1.22% 2,468,645 $8.00 $8.35 $7.96
10 Apr 2025 $8.21 $0.20 2.50% 3,802,768 $8.27 $8.35 $8.09
09 Apr 2025 $8.01 $0.20 2.56% 3,575,374 $7.76 $8.01 $7.76
08 Apr 2025 $7.81 $0.02 0.26% 3,592,274 $7.78 $7.92 $7.65
07 Apr 2025 $7.79 $0.01 0.13% 4,988,819 $7.50 $7.81 $7.40
04 Apr 2025 $7.78 $-0.06 -0.77% 2,532,743 $7.70 $7.84 $7.63
03 Apr 2025 $7.84 $-0.02 -0.25% 2,461,546 $7.77 $7.90 $7.74
02 Apr 2025 $7.86 $-0.03 -0.38% 1,559,256 $7.90 $7.93 $7.78
01 Apr 2025 $7.89 $-0.04 -0.50% 2,634,300 $8.04 $8.05 $7.86
31 Mar 2025 $7.93 $-0.05 -0.63% 2,561,282 $7.93 $8.13 $7.89
28 Mar 2025 $7.98 $0.09 1.14% 4,472,890 $7.89 $8.19 $7.86
27 Mar 2025 $7.89 $-0.16 -1.99% 2,676,743 $8.02 $8.02 $7.82
26 Mar 2025 $8.05 $0.03 0.37% 2,106,243 $8.00 $8.12 $7.97
25 Mar 2025 $8.02 $-0.03 -0.37% 2,038,965 $8.00 $8.09 $7.88
24 Mar 2025 $8.05 $-0.08 -0.98% 2,549,763 $8.10 $8.17 $7.97
21 Mar 2025 $8.13 $-0.23 -2.75% 9,975,799 $8.32 $8.35 $8.11
20 Mar 2025 $8.36 $0.04 0.48% 4,684,866 $8.24 $8.41 $8.23
19 Mar 2025 $8.32 $-0.21 -2.46% 7,322,790 $8.69 $8.87 $8.30
18 Mar 2025 $8.53 $-0.32 -3.62% 2,684,636 $8.90 $8.93 $8.52

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Dec 2024 David Bortolussi Issued 538,336 $3,063,131
Issue of securities. 1,729,582 performance rights
30 Aug 2024 David Bortolussi Buy 490,906 $2,744,164
Conversion of securities.
30 Aug 2024 David Bortolussi Exercise 490,906 $2,744,164
Conversion of securities. 1,191,246 performance rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
Ms Philippa (Pip) Mary Greenwood Non-Executive ChairmanNon-Executive Director Jul 2019
Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
Ms Sandra Yu Non-Executive Director Mar 2022
Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
Mr Antonio (Tonet) Rivera Non-Executive Director Nov 2024
Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Mr Rivera worked for Mead Johnson Nutrition from 2002 to 2017, in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Mr Rivera has worked as a supply chain consultant.
Mr Lain Jager Non-Executive Director Dec 2024
Mr Jager brings international, agribusiness leadership experience to the Board through his former role as CEO of Zespri International. Since stepping down from Zespri in 2017, Lain has on private business interests including personal investments in a range of entrepreneurial, technology and agriculture related businesses. Mr Jager is based in New Zealand. The Board has determined that Mr Jager will be an independent director. He will also be a member of the Boards People and Remuneration Committee.
Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
-
Jaron McVicar Company SecretaryGeneral Counsel
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 113,290,528 15.67%
Citicorp Nominees Pty Limited 96,163,814 13.30%
BNP Paribas Nominees NZ Limited Bpss40* 42,529,528 5.88%
J P Morgan Nominees Australia Pty Limited 34,661,044 4.79%
HSBC Nominees (New Zealand) Limited* 26,156,306 3.62%
Tea Custodians Limited* 21,013,734 2.91%
HSBC Custody Nominees (Australia) Limited Gsco Eca 20,980,543 2.90%
Accident Compensation Corporation* 20,509,205 2.84%
JPMORGAN Chase Bank* 18,595,095 2.57%
New Zealand Superannuation Fund Nominees Limited* 17,659,815 2.44%
Citibank Nominees (NZ) Ltd* 15,787,511 2.18%
New Zealand Depository Nominee 14,021,429 1.94%
National Nominees Limited 13,425,469 1.86%
HSBC Nominees (New Zealand) Limited* i 9,463,432 1.31%
Premier Nominees Limited* 8,473,699 1.17%
Public Trust* 7,323,398 1.01%
UBS Nominees Pty Ltd 6,938,917 0.96%
New Zealand Permanent Trustees Limited* 6,325,699 0.88%
BNP Paribas Noms Pty Ltd 6,123,304 0.85%
JBWere (NZ) Nominees Limited 5,945,531 0.82%

Profile

since

Note